These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 23664133

  • 21. Off-label use of antiepileptic drugs for the treatment of neonatal seizures.
    Silverstein FS, Ferriero DM.
    Pediatr Neurol; 2008 Aug; 39(2):77-9. PubMed ID: 18639748
    [Abstract] [Full Text] [Related]

  • 22. A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures.
    Usery JB, Michael LM, Sills AK, Finch CK.
    J Neurooncol; 2010 Sep; 99(2):251-60. PubMed ID: 20146087
    [Abstract] [Full Text] [Related]

  • 23. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD, Huff AD, Knupp KG, Valuck RJ.
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus.
    Kim JS, Lee JH, Ryu HW, Lim BC, Hwang H, Chae JH, Choi J, Kim KJ, Hwang YS, Kim H.
    Pediatr Emerg Care; 2014 Aug; 30(8):525-8. PubMed ID: 25062293
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM, Almas M, Emir B, Giordano S, Leon T.
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [Abstract] [Full Text] [Related]

  • 27. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E.
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [Abstract] [Full Text] [Related]

  • 28. Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
    Snoeck E, Stockis A.
    Epilepsy Res; 2007 Mar; 73(3):284-91. PubMed ID: 17196793
    [Abstract] [Full Text] [Related]

  • 29. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
    Garrity LC, Turner M, Standridge SM.
    Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of levetiracetam in neonates with seizures.
    Merhar SL, Schibler KR, Sherwin CM, Meinzen-Derr J, Shi J, Balmakund T, Vinks AA.
    J Pediatr; 2011 Jul; 159(1):152-154.e3. PubMed ID: 21592494
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
    Maitre NL, Smolinsky C, Slaughter JC, Stark AR.
    J Perinatol; 2013 Nov; 33(11):841-6. PubMed ID: 24051577
    [Abstract] [Full Text] [Related]

  • 34. Population pharmacokinetic model of levetiracetam in Korean neonates with seizures
.
    Jung YS, Lee SM, Park MS, Park K.
    Int J Clin Pharmacol Ther; 2018 May; 56(5):217-223. PubMed ID: 29393846
    [Abstract] [Full Text] [Related]

  • 35. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG, Hirsch E.
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studies.
    Sharpe C, Yang DZ, Haas RH, Reiner GE, Lee L, Capparelli EV, NEOLEV2 Investigators.
    Arch Dis Child; 2024 Sep 25; 109(10):854-860. PubMed ID: 38902005
    [Abstract] [Full Text] [Related]

  • 37. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C, Marchal C, Dureau-Pournin C, Lassalle R, Jové J, Robinson P, Lavernhe G, Vespignani H, Moore N, Fourrier-Réglat A, Eulev Study Group.
    Pharmacoepidemiol Drug Saf; 2012 Nov 25; 21(11):1183-9. PubMed ID: 22972760
    [Abstract] [Full Text] [Related]

  • 38. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA, Kao LS, Kozar R, Holcomb JB.
    J Trauma; 2011 Aug 25; 71(2):375-9. PubMed ID: 21825941
    [Abstract] [Full Text] [Related]

  • 39. A Review on Pharmacokinetics of Levetiracetam in Neonates.
    Agrawal A, Banergee A.
    Curr Drug Metab; 2017 Oct 16; 18(8):727-734. PubMed ID: 28595534
    [Abstract] [Full Text] [Related]

  • 40. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr 16; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.